IP Library Assignment 027699/0733
Patent Assignment
Reel/Frame 027699/0733

Assignment of Assignor's Interest

Recorded: 2012-02-14 Pages: 3
Assignors
LEVEILLARD, THIERRY
Executed: 2003-10-13
SAHEL, JOSE ALAIN
Executed: 2003-10-11
MOHAND-SAID, SADDEK
Executed: 2003-10-13
HICKS, DAVID
Executed: 2003-10-03
Assignees
NOVARTIS AG
LICHTSTRASSE 35, BASEL, 4056, SWITZERLAND
UNIVERSITE LOUIS PASTEUR
4, RUE BLAISE PASCAL, STRASBOURG, 67000, FRANCE
Covered Properties (2)
Methods of Increasing Rdcvf 1 or Rdcvf 2 Polypeptides in Retinal Cells
Patent: 8,394,756 →
Application: 13/348,383 →
Publication: US 2012/0108523
Compositions Comprising Polynucleotides Encoding RDCVF1 or RDCVF2
Patent: 8,518,695 →
Application: 13/348,435 →
Publication: US 2012/0108657
Related Assignments (4)
Other recorded transfers of the patents in this record — the chain of ownership.
Merger Feb 14, 2012
From: UNIVERSITE LOUIS PASTEUR
To: UNIVERSITE DE STRASBOURG
Reel/Frame 027699/0933 →
Security Agreement Aug 15, 2013
From: WELLSTAT OPHTHALMICS CORPORATION
To: WHITE OAK GLOBAL ADVISORS, LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 031030/0720 →
Security Agreement Sep 17, 2013
From: WELLSTAT OPHTHALMICS CORPORATION
To: PDL BIOPHARMA, INC.
Reel/Frame 031227/0182 →
Release of Security Interest Jan 21, 2021
From: WHITE OAK GLOBAL ADVISORS, LLC, AS ADMINISTRATIVE AGENT
To: WELLSTAT OPHTHALMICS CORPORATION
Reel/Frame 054983/0577 →